Lifeboat Foundation

New Delhi: Six central forensic laboratories in the country will soon be upgraded for carrying out efficient and scientific investigation in serious and heinous crimes, officials said on Sunday.

The central forensic science laboratories (CFSLs) which will be upgraded with capacity enhancement are located at Chandigarh, Hyderabad, Kolkata, Bhopal, Pune and Guwahati.

“The Ministry of Home Affairs has decided to enhance the capacity of six CFSLs under the Directorate of Forensic Science Services in the area of forensic psychology involving external experts,” an official said.

Human-animal hybrids are set to be developed at the University of Tokyo after the Japanese government recently lifted a ban on the controversial stem-cell research.

Hiromitsu Nakauchi—director for Stem Cell Biology and Regenerative Medicine at the University of Tokyo and team leader at Stanford’s Nakauchi Lab—is the first to receive approval for the questionable experiments which will attempt to grow human cells in rat and mouse embryos before being brought to term in a surrogate animal.

Despite many feeling that such studies are the equivalent of playing God, scientists say that the objective is far from sinister. It’s theorized that developing animals with organs constructed from human cells will create organs that can then be used for transplants in humans, cutting the long organ donation waitlists.

Approval could arrive in as few as six months.

At the start of this decade, the federal government called out consumer DNA testing as a burgeoning scam industry. Little did we know how it would explode in popularity.

In 2010, the U.S. Government Accountability Office (GAO) published an investigative report that bashed consumer DNA test companies for misleading the public. It accused them of deceptively claiming their products could predict the odds of developing more than a dozen medical conditions; some even went as far to offer equally dubious dietary supplements. The report had followed a similar lambasting of the industry by the GAO in 2006.

The American X-plane series has a long and storied history stretching all the way back to the Bell X-1 that made supersonic flight a reality. NASA, the Air Force, and other parts of the government have used X-planes to explore the flight mechanics of vertical takeoff and landing (VTOL), movable wings, and much more. Now, NASA is working on the first manned X-plane in decades, the all-electric X-57 Maxwell.

NASA started working on the X-57 in 2015, but it’s not building its electric plane from the ground up. The team started with a Tecnam P2006T twin-engine propeller plane, which it is modifying in stages. NASA hasn’t flown the aircraft yet, but it has deemed the X-57 ready for its public debut. The press was allowed to view the X-57 last week at NASA’s Armstrong Flight Research Center in Edwards Air Force Base.

The X-57 is currently in its “Mod II” configuration, which is the first featuring entirely electric flight hardware. The plane has electric cruise motors where two combustion motors were in the original aircraft. Mod III and IV will complete the X-57’s transformation from a noisy combustion plane to a quieter, more efficient electric one.

“Demonstrate That Top Financial and Tech Corporations Are Committed to Longevity”

This week two Landmark International Longevity Summits in London attracted the attention of scientists, government officials, major financial corporations, insurance companies, investment banks, and technology companies from around the world. The Landmark AI for Longevity Summit and the First International Longevity Policy and Governance Summit at King’s College London are expected to become the world-leading forums for the Longevity Industry.

There’s reason to think fruits of the collaboration may interest the military. The Pentagon’s cloud strategy lists four tenets for the JEDI contract, among them the improvement of its AI capabilities. This comes amidst its broader push to tap tech-industry AI development, seen as far ahead of the government’s.

Microsoft’s $10 billion Pentagon contract puts the independent artificial-intelligence lab OpenAI in an awkward position.

There are key moments in the history of every disruptive technology that can make or break its public perception and acceptance. For CRISPR-based genome editing, such a moment occurred 1 year ago—an unsettling push into an era that will test how society decides to use this revolutionary technology.

In November 2018, at the Second International Summit on Human Genome Editing in Hong Kong, scientist He Jiankui announced that he had broken the basic medical mantra of “do no harm” by using CRISPR-Cas9 to edit the genomes of two human embryos in the hope of protecting the twin girls from HIV. His risky and medically unnecessary work stunned the world and defied prior calls by my colleagues and me, and by the U.S. National Academies of Sciences and of Medicine, for an effective moratorium on human germline editing. It was a shocking reminder of the scientific and ethical challenges raised by this powerful technology. Once the details of He’s work were revealed, it became clear that although human embryo editing is relatively easy to achieve, it is difficult to do well and with responsibility for lifelong health outcomes.

It is encouraging that scientists around the globe responded by opening a deeper public conversation about how to establish stronger safeguards and build a viable path toward transparency and responsible use of CRISPR technology. In the year since He’s announcement, some scientists have called for a global but temporary moratorium on heritable human genome editing. However, I believe that moratoria are no longer strong enough countermeasures and instead, stakeholders must engage in thoughtfully crafting regulations of the technology without stifling it. In this vein, the World Health Organization (WHO) is pushing government regulators to engage, lead, and act. In July, WHO issued a statement requesting that regulatory agencies in all countries disallow any human germline editing experiments in the clinic and in August, announced the first steps in establishing a registry for future such studies.

Shanghai hosted one of the largest gatherings of Nobel laureates in the world last week, with 44 Nobel Prize-winning scientists in the city for a government-sponsored forum with the lofty goal of discussing science and technology for the “common destiny of mankind”.

Chinese academics and young scientists join global scientific elite to explore frontiers of research.